{"id":"https://openalex.org/W4361890157","doi":"https://doi.org/10.1158/1078-0432.22481562","title":"Supplementary Table S2 from Heterogeneity in NECTIN4 Expression Across Molecular Subtypes of Urothelial Cancer Mediates Sensitivity to Enfortumab Vedotin","display_name":"Supplementary Table S2 from Heterogeneity in NECTIN4 Expression Across Molecular Subtypes of Urothelial Cancer Mediates Sensitivity to Enfortumab Vedotin","publication_year":2023,"publication_date":"2023-03-31","ids":{"openalex":"https://openalex.org/W4361890157","doi":"https://doi.org/10.1158/1078-0432.22481562"},"language":"en","primary_location":{"id":"doi:10.1158/1078-0432.22481562","doi":"https://doi.org/10.1158/1078-0432.22481562","is_oa":true,"landing_page_url":"https://doi.org/10.1158/1078-0432.22481562","pdf_url":"https://aacr.figshare.com/articles/journal_contribution/Supplementary_Table_S2_from_Heterogeneity_in_i_NECTIN4_i_Expression_Across_Molecular_Subtypes_of_Urothelial_Cancer_Mediates_Sensitivity_to_Enfortumab_Vedotin/22481562/1/files/39933072.pdf","source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},"volume":null,"type":"supplementary-materials","is_traditional":false,"indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://aacr.figshare.com/articles/journal_contribution/Supplementary_Table_S2_from_Heterogeneity_in_i_NECTIN4_i_Expression_Across_Molecular_Subtypes_of_Urothelial_Cancer_Mediates_Sensitivity_to_Enfortumab_Vedotin/22481562/1/files/39933072.pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5079611269","display_name":"Carissa Ellen Chu","orcid":"https://orcid.org/0000-0003-3065-389X","observed_orcids":["https://orcid.org/0000-0003-3065-389X"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Carissa E. Chu","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5039517115","display_name":"Martin Sj\u00f6str\u00f6m","orcid":"https://orcid.org/0000-0002-2629-9966","observed_orcids":["https://orcid.org/0000-0002-2629-9966"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Martin Sj\u00f6str\u00f6m","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-2629-9966","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5002133501","display_name":"Emily A. Egusa","orcid":"https://orcid.org/0000-0003-2017-5708","observed_orcids":["https://orcid.org/0000-0003-2017-5708"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Emily A. Egusa","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5029125718","display_name":"Ewan A. Gibb","orcid":"https://orcid.org/0000-0001-9836-1434","observed_orcids":["https://orcid.org/0000-0001-9836-1434"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Ewan A. Gibb","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5053590643","display_name":"Michelle L. Badura","orcid":"https://orcid.org/0000-0001-5325-8097","observed_orcids":["https://orcid.org/0000-0001-5325-8097"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Michelle L. Badura","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100370162","display_name":"Jun Zhu","orcid":"https://orcid.org/0000-0003-1938-4705","observed_orcids":["https://orcid.org/0000-0003-1938-4705"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Jun Zhu","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5031234862","display_name":"Vadim S. Koshkin","orcid":"https://orcid.org/0000-0003-2277-8668","observed_orcids":["https://orcid.org/0000-0003-2277-8668"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Vadim S. Koshkin","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5041474903","display_name":"Bradley A. Stohr","orcid":"https://orcid.org/0000-0002-5836-2624","observed_orcids":["https://orcid.org/0000-0002-5836-2624"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Bradley A. Stohr","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5006235300","display_name":"Maxwell V. Meng","orcid":"https://orcid.org/0009-0007-8838-8212","observed_orcids":["https://orcid.org/0009-0007-8838-8212"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Maxwell V. Meng","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5073387299","display_name":"Raj S. Pruthi","orcid":"https://orcid.org/0000-0002-4376-2019","observed_orcids":["https://orcid.org/0000-0002-4376-2019"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Raj S. Pruthi","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5079570071","display_name":"Terence W. Friedlander","orcid":"https://orcid.org/0000-0002-3630-4941","observed_orcids":["https://orcid.org/0000-0002-3630-4941"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Terence W. Friedlander","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-3630-4941","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5041923034","display_name":"Yair Lotan","orcid":"https://orcid.org/0000-0001-5692-2723","observed_orcids":["https://orcid.org/0000-0001-5692-2723"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Yair Lotan","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0001-5692-2723","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5050196540","display_name":"Peter C. Black","orcid":"https://orcid.org/0000-0002-2919-7068","observed_orcids":["https://orcid.org/0000-0002-2919-7068"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Peter C. Black","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-2919-7068","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5046834675","display_name":"Sima P. Porten","orcid":"https://orcid.org/0000-0002-3948-4968","observed_orcids":["https://orcid.org/0000-0002-3948-4968"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Sima P. Porten","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5020006331","display_name":"Felix Yi-Chung Feng","orcid":"https://orcid.org/0000-0002-0963-7687","observed_orcids":["https://orcid.org/0000-0002-0963-7687","https://orcid.org/0000-0001-9756-4037"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Felix Y. Feng","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5019176693","display_name":"Jonathan Chou","orcid":"https://orcid.org/0000-0003-1258-0391","observed_orcids":["https://orcid.org/0000-0003-1258-0391"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Jonathan Chou","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0003-1258-0391","affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":true,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10458","display_name":"Bladder and Urothelial Cancer Treatments","score":0.98580002784729,"subfield":{"id":"https://openalex.org/subfields/2746","display_name":"Surgery"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10458","display_name":"Bladder and Urothelial Cancer Treatments","score":0.98580002784729,"subfield":{"id":"https://openalex.org/subfields/2746","display_name":"Surgery"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10543","display_name":"Prostate Cancer Treatment and Research","score":0.0026000000070780516,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.002099999925121665,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/nectin-4","display_name":"nectin-4","score":0.9990000128746033},{"id":"https://openalex.org/keywords/urothelial-carcinoma","display_name":"urothelial carcinoma","score":0.9710000157356262},{"id":"https://openalex.org/keywords/enfortumab-vedotin","display_name":"enfortumab vedotin","score":0.9549999833106995},{"id":"https://openalex.org/keywords/molecular-subtypes","display_name":"molecular subtypes","score":0.8059999942779541},{"id":"https://openalex.org/keywords/crispri-knockdown","display_name":"CRISPRi knockdown","score":0.7680000066757202},{"id":"https://openalex.org/keywords/guide-rna","display_name":"guide RNA","score":0.7620000243186951},{"id":"https://openalex.org/keywords/qpcr-primers","display_name":"qPCR primers","score":0.8659999966621399},{"id":"https://openalex.org/keywords/gene-expression-heterogeneity","display_name":"gene expression heterogeneity","score":0.7039999961853027},{"id":"https://openalex.org/keywords/drug-sensitivity","display_name":"drug sensitivity","score":0.6359999775886536}],"concepts":[{"id":"https://openalex.org/C173396325","wikidata":"https://www.wikidata.org/wiki/Q1501275","display_name":"Gene knockdown","level":3,"score":0.7451754808425903},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.5238288044929504},{"id":"https://openalex.org/C153911025","wikidata":"https://www.wikidata.org/wiki/Q7202","display_name":"Molecular biology","level":1,"score":0.48796647787094116},{"id":"https://openalex.org/C21200559","wikidata":"https://www.wikidata.org/wiki/Q7451068","display_name":"Sensitivity (control systems)","level":2,"score":0.4304879903793335},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.4153299927711487},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.41402286291122437},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.38787758350372314},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.36497557163238525},{"id":"https://openalex.org/C70721500","wikidata":"https://www.wikidata.org/wiki/Q177005","display_name":"Computational biology","level":1,"score":0.33339959383010864},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.293906569480896},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.22889447212219238},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.12226340174674988},{"id":"https://openalex.org/C127413603","wikidata":"https://www.wikidata.org/wiki/Q11023","display_name":"Engineering","level":0,"score":0.055215656757354736},{"id":"https://openalex.org/C24326235","wikidata":"https://www.wikidata.org/wiki/Q126095","display_name":"Electronic engineering","level":1,"score":0.0}],"mesh":[],"locations_count":3,"locations":[{"id":"doi:10.1158/1078-0432.22481562","doi":"https://doi.org/10.1158/1078-0432.22481562","is_oa":true,"landing_page_url":"https://doi.org/10.1158/1078-0432.22481562","pdf_url":"https://aacr.figshare.com/articles/journal_contribution/Supplementary_Table_S2_from_Heterogeneity_in_i_NECTIN4_i_Expression_Across_Molecular_Subtypes_of_Urothelial_Cancer_Mediates_Sensitivity_to_Enfortumab_Vedotin/22481562/1/files/39933072.pdf","source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},{"id":"doi:10.1158/1078-0432.22481562.v1","doi":"https://doi.org/10.1158/1078-0432.22481562.v1","is_oa":true,"landing_page_url":"https://doi.org/10.1158/1078-0432.22481562.v1","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},{"id":"pmh:oai:figshare.com:article/22481562","doi":null,"is_oa":true,"landing_page_url":"https://figshare.com/articles/journal_contribution/Supplementary_Table_S2_from_Heterogeneity_in_i_NECTIN4_i_Expression_Across_Molecular_Subtypes_of_Urothelial_Cancer_Mediates_Sensitivity_to_Enfortumab_Vedotin/22481562","pdf_url":null,"source":{"id":"https://openalex.org/S4377196282","display_name":"Figshare","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I4210132348","host_organization_name":"Figshare (United Kingdom)","host_organization_lineage":["https://openalex.org/I4210132348"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"","raw_type":"Text"}],"best_oa_location":{"id":"doi:10.1158/1078-0432.22481562","doi":"https://doi.org/10.1158/1078-0432.22481562","is_oa":true,"landing_page_url":"https://doi.org/10.1158/1078-0432.22481562","pdf_url":"https://aacr.figshare.com/articles/journal_contribution/Supplementary_Table_S2_from_Heterogeneity_in_i_NECTIN4_i_Expression_Across_Molecular_Subtypes_of_Urothelial_Cancer_Mediates_Sensitivity_to_Enfortumab_Vedotin/22481562/1/files/39933072.pdf","source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.8560000061988831}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W4361890157.pdf","grobid_xml":"https://content.openalex.org/works/W4361890157.grobid-xml"},"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4361947414","https://openalex.org/W3166074522","https://openalex.org/W4365510562","https://openalex.org/W4311928016","https://openalex.org/W4361959155","https://openalex.org/W7133229556","https://openalex.org/W7162498316","https://openalex.org/W6965384534","https://openalex.org/W7214180257","https://openalex.org/W3185293105"],"abstract_inverted_index":{"NECTIN4":[0],"guide":[1],"RNA":[2],"and":[3,11],"qPCR":[4,12],"primer":[5],"sequences":[6],"used":[7],"for":[8],"CRISPRi":[9],"knockdown":[10],"experiments,":[13],"respectively.":[14]},"counts_by_year":[],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2023-04-05T00:00:00"}